User profiles for "author:JF Standing"

Joseph F Standing

Professor of Pharmacometrics, University College London
Verified email at ucl.ac.uk
Cited by 3392

[HTML][HTML] What concentration of tranexamic acid is needed to inhibit fibrinolysis? A systematic review of pharmacodynamics studies

…, H Shakur-Still, RL Medcalf, JF Standing… - Blood coagulation & …, 2019 - journals.lww.com
Intravenous tranexamic acid (TXA) reduces death because of bleeding in patients with
trauma and postpartum haemorrhage. However, in some settings intravenous injection is not …

Understanding and applying pharmacometric modelling and simulation in clinical practice and research

JF Standing - British journal of clinical pharmacology, 2017 - Wiley Online Library
Understanding the dose–concentration–effect relationship is a fundamental component of
clinical pharmacology. Interpreting data arising from observations of this relationship …

[HTML][HTML] Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an …

…, DB Richards, J Dorward, DM Lowe, JF Standing… - The Lancet, 2023 - thelancet.com
Background The safety, effectiveness, and cost-effectiveness of molnupiravir, an oral
antiviral medication for SARS-CoV-2, has not been established in vaccinated patients in the …

Pharmacokinetic studies in children: recommendations for practice and research

CIS Barker, JF Standing, LE Kelly, LH Faught… - Archives of disease in …, 2018 - adc.bmj.com
Optimising the dosing of medicines for neonates and children remains a challenge. The
importance of pharmacokinetic (PK) and pharmacodynamic (PD) research is recognised …

Paediatric formulations—Getting to the heart of the problem

JF Standing, C Tuleu - International journal of pharmaceutics, 2005 - Elsevier
Many medicines prescribed for children are unlicensed. Solid dosage forms present
problems as children have difficulty swallowing whole tablets or capsules. When medicines …

[HTML][HTML] Pharmacokinetic and pharmacodynamic study of intranasal and intravenous dexmedetomidine

…, S Goulay-Dufaÿ, Y Sheng, JF Standing… - British journal of …, 2018 - Elsevier
Background Intranasal dexmedetomidine produces safe, effective sedation in children and
adults. It may be administered by drops from a syringe or by nasal mucosal atomisation …

Scaling clearance in paediatric pharmacokinetics: all models are wrong, which are useful?

…, CIS Barker, M Sharland, JF Standing - British journal of …, 2017 - Wiley Online Library
Linked Articles This article is commented on in the editorial by Holford NHG and Anderson
BJ. Why standards are useful for predicting doses. Br J Clin Pharmacol 2017; 83: 685–7. doi …

Augmented renal clearance implies a need for increased amoxicillin-clavulanic acid dosing in critically ill children

PAJG De Cock, JF Standing, CIS Barker… - Antimicrobial agents …, 2015 - Am Soc Microbiol
There is little data available to guide amoxicillin-clavulanic acid dosing in critically ill
children. The primary objective of this study was to investigate the pharmacokinetics of both …

[HTML][HTML] Pharmacokinetic–pharmacodynamic modeling in pediatric drug development, and the importance of standardized scaling of clearance

…, CIS Barker, M Sharland, JF Standing - Clinical …, 2019 - Springer
Pharmacokinetic/pharmacodynamic (PKPD) modeling is important in the design and
conduct of clinical pharmacology research in children. During drug development, PKPD …

Advanced methods for dose and regimen finding during drug development: summary of the EMA/EFPIA workshop on dose finding (London 4–5 December 2014)

…, PH Van Der Graaf, JF Standing… - CPT …, 2017 - Wiley Online Library
Inadequate dose selection for confirmatory trials is currently still one of the most challenging
issues in drug development, as illustrated by high rates of late‐stage attritions in clinical …